# Lixte Biotechnology Holdings Inc. (LIXT)

Source: https://www.quantisnow.com/company/LIXT
Generated: 2026-11-06T22:35:28.739Z

- Ticker: LIXT
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- SEC CIK: 0001335105
- Website: lixte.com

## About

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company that uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. The company primarily focuses on inhibitors of protein phosphatases that are used alone and in combination with cytotoxic agents and/or x-ray and immune checkpoint blockers; and encompasses two major categories of compounds at various stages of pre-clinical and clinical development. It develops two series of pharmacologically active drugs, which include the LB-100 series that consists of novel structures, which might be useful in the treatment of cancers, and vascular and metabolic diseases; and LB-200 series for the treatment of chronic hereditary diseases, such as Gaucher's disease, as well as cancer and neurodegenerative diseases. Lixte Biotechnology Holdings, Inc. has a clinical trial research agreement with the Moffitt Cancer Center and Research Institute Hospital Inc.; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; pharmacologic study with the National Cancer Institute; and clinical research support agreement with City of Hope National Medical Center to carry out a Phase 1b clinical trial of its LB-100, a protein phosphatase inhibitor for small cell lung cancer. The company was incorporated in 2005 and is based in East Setauket, New York.

## Latest LIXT news and filings

- 2026-10-06 16:18 UTC [SEC Form 8-K] [SEC Form 8-K filed by Lixte Biotechnology Holdings Inc.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-lixte-biotechnology-holdings-inc-6738651)
- 2026-09-30 20:06 UTC [SEC Form 8-K] [Lixte Biotechnology Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Financial Statements and Exhibits](https://www.quantisnow.com/insight/lixte-biotechnology-holdings-inc-filed-sec-form-8-k-entry-into-6730605)
- 2026-09-17 20:10 UTC [SEC Form 8-K] [Amendment: Lixte Biotechnology Holdings Inc. filed SEC Form 8-K: Financial Statements and Exhibits](https://www.quantisnow.com/insight/amendment-lixte-biotechnology-holdings-inc-filed-sec-form-8-k-financial-6719128)
- 2026-08-14 12:30 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Lixte Biotechnology Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-lixte-biotechnology-holdings-inc-6682007)
- 2026-07-31 13:10 UTC [SEC Form 8-K] [Lixte Biotechnology Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/lixte-biotechnology-holdings-inc-filed-sec-form-8-k-regulation-fd-6657378)
- 2026-07-27 12:30 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Lixte Biotechnology Holdings Inc.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-lixte-biotechnology-holdings-inc-6649161)
- 2026-07-17 21:29 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Lixte Biotechnology Holdings Inc.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-lixte-biotechnology-holdings-inc-6641470)
- 2026-07-10 15:43 UTC [SEC Form 8-K] [Lixte Biotechnology Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/lixte-biotechnology-holdings-inc-filed-sec-form-8-k-regulation-fd-6633837)
- 2026-07-06 15:40 UTC [AI Energy Pivot Complete: LIXTE Biotechnology Finishes Corporate Rebrand to NOMAD Power Solutions, Begins Trading Under Nasdaq: NMAD](https://www.quantisnow.com/insight/ai-energy-pivot-complete-lixte-biotechnology-finishes-corporate-rebrand-to-6627723)
- 2026-07-06 12:30 UTC [LIXTE Completes Corporate Name Change to NOMAD Power Solutions, Inc.; To Begin Trading Under New Nasdaq Symbol NMAD](https://www.quantisnow.com/insight/lixte-completes-corporate-name-change-to-nomad-power-solutions-inc-6627401)
- 2026-07-02 20:18 UTC [SEC Form 4] [Chief Financial Officer Stazzone Peter was granted 50,000 shares, increasing direct ownership by 100% to 100,000 units (SEC Form 4)](https://www.quantisnow.com/insight/chief-financial-officer-stazzone-peter-was-granted-50000-shares-increasing-6625536)
- 2026-07-02 20:16 UTC [SEC Form 4] [Director Sawyer Jason David was granted 40,000 shares, increasing direct ownership by 160% to 65,000 units (SEC Form 4)](https://www.quantisnow.com/insight/director-sawyer-jason-david-was-granted-40000-shares-increasing-direct-6625511)
- 2026-07-02 20:13 UTC [SEC Form 4] [CEO and Chairman of the Board Pursglove Geordan Garrett was granted 350,000 shares, increasing direct ownership by 100% to 700,000 units (SEC Form 4)](https://www.quantisnow.com/insight/ceo-and-chairman-of-the-board-pursglove-geordan-garrett-was-6625400)
- 2026-07-02 20:11 UTC [SEC Form 4] [Director Primus Guy Warren was granted 15,000 shares, increasing direct ownership by 60% to 40,000 units (SEC Form 4)](https://www.quantisnow.com/insight/director-primus-guy-warren-was-granted-15000-shares-increasing-direct-6625348)
- 2026-07-02 20:10 UTC [SEC Form 4] [Director Holloway Michael Andrew was granted 15,000 shares, increasing direct ownership by 60% to 40,000 units (SEC Form 4)](https://www.quantisnow.com/insight/director-holloway-michael-andrew-was-granted-15000-shares-increasing-direct-6625281)
- 2026-07-02 20:08 UTC [SEC Form 4] [Director Felix Lourdes was granted 30,000 shares, increasing direct ownership by 120% to 55,000 units (SEC Form 4)](https://www.quantisnow.com/insight/director-felix-lourdes-was-granted-30000-shares-increasing-direct-ownership-6625221)
- 2026-07-02 20:00 UTC [SEC Form 8-K] [Lixte Biotechnology Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/lixte-biotechnology-holdings-inc-filed-sec-form-8-k-entry-into-6624979)
- 2026-07-02 16:51 UTC [SEC Form 3] [SEC Form 3 filed by new insider Travaglini John Francis](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-travaglini-john-francis-6624719)
- 2026-07-02 12:30 UTC [LIXTE COMPLETES MERGER WITH NOMAD TRANSPORTABLE POWER SYSTEMS](https://www.quantisnow.com/insight/lixte-completes-merger-with-nomad-transportable-power-systems-6624328)
- 2026-06-26 12:30 UTC [LIXTE Joins Russell Microcap Index](https://www.quantisnow.com/insight/lixte-joins-russell-microcap-index-6616787)
- 2026-06-18 20:00 UTC [SEC Form 8-K] [Lixte Biotechnology Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/lixte-biotechnology-holdings-inc-filed-sec-form-8-k-entry-into-6608440)
- 2026-06-18 15:10 UTC [A Nasdaq Company Just Reinvented Itself as a Power Company — and Bet It All on the AI Energy Crunch](https://www.quantisnow.com/insight/a-nasdaq-company-just-reinvented-itself-as-a-power-company-6608249)
- 2026-06-18 13:15 UTC [The AI Boom's Real Bottleneck Is Power — and One Nasdaq Company Is Reinventing Itself to Solve It](https://www.quantisnow.com/insight/the-ai-booms-real-bottleneck-is-power-and-one-nasdaq-6608161)
- 2026-06-18 12:30 UTC [LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026](https://www.quantisnow.com/insight/lixte-biotechnology-provides-update-on-nomad-acquisition-transaction-expected-to-6608038)
- 2026-06-16 20:00 UTC [SEC Form 8-K] [Lixte Biotechnology Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/lixte-biotechnology-holdings-inc-filed-sec-form-8-k-entry-into-6604557)
- 2026-06-12 14:45 UTC [The New Bottleneck Isn't Computing Power — It's Just Power](https://www.quantisnow.com/insight/the-new-bottleneck-isnt-computing-power-its-just-power-6599790)
- 2026-06-12 12:59 UTC [From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch](https://www.quantisnow.com/insight/from-cancer-drugs-to-kilowatts-a-nasdaq-companys-bet-on-6599682)
- 2026-06-12 12:30 UTC [LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)](https://www.quantisnow.com/insight/lixte-biotechnology-to-acquire-nomad-transportable-power-systems-the-market-6599626)
- 2026-06-09 23:26 UTC [SEC Form SCHEDULE 13G filed by Lixte Biotechnology Holdings Inc.](https://www.quantisnow.com/insight/sec-form-schedule-13g-filed-by-lixte-biotechnology-holdings-inc-6596067)
- 2026-06-04 21:01 UTC [SEC Form 8-K] [Lixte Biotechnology Holdings Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/lixte-biotechnology-holdings-inc-filed-sec-form-8-k-entry-into-6589875)
- 2026-06-04 20:40 UTC [SEC Form 424B5] [SEC Form 424B5 filed by Lixte Biotechnology Holdings Inc.](https://www.quantisnow.com/insight/sec-form-424b5-filed-by-lixte-biotechnology-holdings-inc-6589741)
- 2026-06-03 12:30 UTC [Public Offering] [LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth](https://www.quantisnow.com/insight/lixte-biotechnology-announces-16566027-registered-direct-offering-priced-at-the-6585999)
- 2026-06-01 20:01 UTC [SEC Form 4] [Director Porter Stuart D was granted 25,000 shares (SEC Form 4)](https://www.quantisnow.com/insight/director-porter-stuart-d-was-granted-25000-shares-sec-form-6581446)
- 2026-06-01 20:00 UTC [SEC Form 3] [SEC Form 3 filed by new insider Porter Stuart D](https://www.quantisnow.com/insight/sec-form-3-filed-by-new-insider-porter-stuart-d-6581429)
- 2026-06-01 12:55 UTC [SEC Form 8-K] [Lixte Biotechnology Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits](https://www.quantisnow.com/insight/lixte-biotechnology-holdings-inc-filed-sec-form-8-k-leadership-update-6580914)
- 2026-06-01 12:50 UTC [Leadership Update] [LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors](https://www.quantisnow.com/insight/lixte-biotechnology-announces-strategic-transformation-into-ai-energy-infrastructure-equipment-6580898)
- 2026-05-14 21:18 UTC [LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update](https://www.quantisnow.com/insight/lixte-biotechnology-files-first-quarter-2026-quarterly-report-on-form-6554824)
- 2026-05-14 20:50 UTC [SEC Form 10-Q] [SEC Form 10-Q filed by Lixte Biotechnology Holdings Inc.](https://www.quantisnow.com/insight/sec-form-10-q-filed-by-lixte-biotechnology-holdings-inc-6554601)
- 2026-04-17 20:15 UTC [SEC Form 4] [SEC Form 4 filed by Felix Lourdes](https://www.quantisnow.com/insight/sec-form-4-filed-by-felix-lourdes-6504862)
- 2026-04-17 20:15 UTC [SEC Form 4] [SEC Form 4 filed by Pursglove Geordan Garrett](https://www.quantisnow.com/insight/sec-form-4-filed-by-pursglove-geordan-garrett-6504834)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/LIXT
- Earnings history: https://www.quantisnow.com/earnings/LIXT
- Dividend history: https://www.quantisnow.com/dividends/LIXT
- Insider transactions: https://www.quantisnow.com/insiders/LIXT
- Options chain: https://www.quantisnow.com/options/LIXT
- SEC 8-K filings only: https://www.quantisnow.com/company/LIXT/8-k
- RSS and alerts for LIXT: https://www.quantisnow.com/docs/rss-feeds.md